Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Molecular Pharmacology|August 14, 2015
Identification of a Highly Conserved Allosteric Binding Site on Mnk1 and Mnk2Sunita K C Basnet, Sarah Diab, Raffaella Schmid, et al.
European Journal of Medicinal Chemistry|September 27, 2015
An integrated approach for discovery of highly potent and selective Mnk inhibitors: Screening, synthesis and SAR analysisTheodosia Teo, Yuchao Yang, Mingfeng Yu, et al.
ACS Medicinal Chemistry Letters|May 18, 2019
Discovery of CDK5 Inhibitors through Structure-Guided ApproachNishat Z Khair, Jimma L Lenjisa, Solomon Tadesse, et al.
Cancers|March 10, 2022
An Orally Bioavailable and Highly Efficacious Inhibitor of CDK9/FLT3 for the Treatment of Acute Myeloid LeukemiaAbel Tesfaye Anshabo, Laychiluh Bantie, Sarah Diab, et al.
Medicinal Chemistry (Shariqah (United Arab Emirates))|December 21, 2018
Discovery of N-Phenyl-4-(1H-pyrrol-3-yl)pyrimidin-2-amine Derivatives as Potent Mnk2 Inhibitors: Design, Synthesis, SAR Analysis, and Evaluation of in vitro Anti-leukaemic ActivityAhmed M Abdelaziz, Sarah Diab, Saiful Islam, et al.
European Journal of Medicinal Chemistry|September 2, 2017
Dual Inhibition of Mnk2 and FLT3 for potential treatment of acute myeloid leukaemiaSarah Diab, Ahmad M Abdelaziz, Peng Li, et al.
European Journal of Medicinal Chemistry|February 11, 2021
Potent and orally bioavailable CDK8 inhibitors: Design, synthesis, structure-activity relationship analysis and biological evaluationMingfeng Yu, Theodosia Teo, Yuchao Yang, et al.
Journal of Medicinal Chemistry|February 5, 2019
3,3'-Disubstituted 5,5'-Bi(1,2,4-triazine) Derivatives with Potent in Vitro and in Vivo Antimalarial ActivityLian Xue, Da-Hua Shi, Jitendra R Harjani, et al.
Pageof 2